APA (7th ed.) Citation

Gowhari Shabgah, A., Al-Obaidi, Z. M. J., Sulaiman Rahman, H., Kamal Abdelbasset, W., Suksatan, W., Bokov, D. O., . . . Gholizadeh Navashenaq, J. (2022). Does CCL19 act as a double-edged sword in cancer development? Clinical & Experimental Immunology, 207(2), 164. https://doi.org/10.1093/cei/uxab039

Chicago Style (17th ed.) Citation

Gowhari Shabgah, Arezoo, et al. "Does CCL19 Act as a Double-edged Sword in Cancer Development?" Clinical & Experimental Immunology 207, no. 2 (2022): 164. https://doi.org/10.1093/cei/uxab039.

MLA (9th ed.) Citation

Gowhari Shabgah, Arezoo, et al. "Does CCL19 Act as a Double-edged Sword in Cancer Development?" Clinical & Experimental Immunology, vol. 207, no. 2, 2022, p. 164, https://doi.org/10.1093/cei/uxab039.